These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21217657)

  • 1. Nomination bungle leaves CIRM leadership in limbo.
    Dolgin E
    Nat Med; 2011 Jan; 17(1):8. PubMed ID: 21217657
    [No Abstract]   [Full Text] [Related]  

  • 2. Open for business.
    Nature; 2007 Mar; 446(7133):232. PubMed ID: 17361139
    [No Abstract]   [Full Text] [Related]  

  • 3. Salary for CIRM head despite deficit.
    Check Hayden E
    Nature; 2008 Dec; 456(7224):851. PubMed ID: 19092899
    [No Abstract]   [Full Text] [Related]  

  • 4. Stem cells: the 3-billion-dollar question.
    Hayden EC
    Nature; 2008 May; 453(7191):18-21. PubMed ID: 18461716
    [No Abstract]   [Full Text] [Related]  

  • 5. Industry concerns mount over CIRM grants.
    Baker M
    Nat Biotechnol; 2007 Oct; 25(10):1063-4. PubMed ID: 17921974
    [No Abstract]   [Full Text] [Related]  

  • 6. California: 'the Stem Cell State'. Interview with Jonathan Thomas.
    Thomas J
    Regen Med; 2011 Nov; 6(6 Suppl):113-5. PubMed ID: 21999272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposition 71 and CIRM--assessing the return on investment.
    Longaker MT; Baker LC; Greely HT
    Nat Biotechnol; 2007 May; 25(5):513-21. PubMed ID: 17483831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. California institute to help stem-cell biotechs.
    Hayden EC
    Nature; 2008 Sep; 455(7212):436-7. PubMed ID: 18818612
    [No Abstract]   [Full Text] [Related]  

  • 9. California prepares to roll out stem-cell funding.
    Dalton R
    Nature; 2005 Oct; 437(7060):800-1. PubMed ID: 16208332
    [No Abstract]   [Full Text] [Related]  

  • 10. Stem-cell projects falter.
    Dalton R
    Nature; 2009 Sep; 461(7260):23. PubMed ID: 19727176
    [No Abstract]   [Full Text] [Related]  

  • 11. Seed money to bring in pioneers.
    Check E
    Nature; 2007 Mar; 446(7133):238-9. PubMed ID: 17361143
    [No Abstract]   [Full Text] [Related]  

  • 12. Wind-down of stem-cell institute leaves a void.
    Loring JF
    Nature; 2019 Aug; 572(7768):155. PubMed ID: 31391566
    [No Abstract]   [Full Text] [Related]  

  • 13. California stem-cell grants awarded.
    Check Hayden E
    Nature; 2009 Nov; 462(7269):22. PubMed ID: 19890299
    [No Abstract]   [Full Text] [Related]  

  • 14. Stem-cell research: after the gold rush.
    Aldhous P
    Nature; 2005 Apr; 434(7034):694-6. PubMed ID: 15815600
    [No Abstract]   [Full Text] [Related]  

  • 15. Q&A: King of the stem cells. Interviewed by Erika Check Hayden.
    Trounson A
    Nature; 2007 Sep; 449(7161):385. PubMed ID: 17898728
    [No Abstract]   [Full Text] [Related]  

  • 16. Fountain of funding for youth.
    Baker M
    Nature; 2007 Jul; 448(7151):384. PubMed ID: 17682132
    [No Abstract]   [Full Text] [Related]  

  • 17. Stem-cell researcher's move attracts funding.
    Check E
    Nature; 2007 Jul; 448(7152):398. PubMed ID: 17653156
    [No Abstract]   [Full Text] [Related]  

  • 18. California dreaming? A new start for regenerative medicine in the Golden State. Interview with Dr. Zach Hall.
    Hall ZW
    Regen Med; 2007 Jan; 2(1):25-8. PubMed ID: 17465772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Californians hash out guide for spending stem-cell billions.
    Knight J
    Nature; 2004 Dec; 432(7018):660. PubMed ID: 15592368
    [No Abstract]   [Full Text] [Related]  

  • 20. Local and global returns from research in stem cells: the case of the California Institute for Regenerative Medicine.
    Alberro J
    Regen Med; 2012 Jul; 7(4):605-13. PubMed ID: 22817632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.